Skip to main content
Caplight Logo









Curiteva, Inc.

Curiteva, Inc.

Private
Tanner, WashingtonHealthcare & Life Scienceshttps://curiteva.com/

Last Round

Seed Round

Jan 5, 2024

Total Funding Raised

$20.5M

Company Overview

Curiteva, Inc. is a medical device and technology company that manufactures and commercializes spinal implant systems to advance spine surgery and improve clinical outcomes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, 3D Printing, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

spinal implantsspinal fusionPEEK implants3D-printed implantsorthopedic devicesosseointegrationsurgical instrumentationadditive manufacturingneurosurgical devicesambulatory surgery centersASCsmedtechspine surgery hardwareporous implants

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Curiteva, Inc. Comparables

Compare Curiteva, Inc. with similar companies based on industry and business-model similarity.

Curiteva, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CTL Amedica Corporation
90%
4WEB Medical
90%
NanoHive Medical
89%

Curiteva, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJan 5, 2024
Series ADec 3, 2020

Key People

Founding team and executive leadership

Bill Voss

Chief Operating Officer

Executive Team

Curiteva, Inc. Investors

Notable investors and investment history

Curiteva, Inc. investors
InvestorRounds
Eastside PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors increased 192% MoM, reaching 5.3K.

  • Mar 31, 2026

    Developing Inspire, the world's first 3D-Printed Trabecular PEEK.

Curiteva, Inc. Filings

Explore SEC and related filing metadata, where available.

Curiteva, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Curiteva, Inc.'s valuation, stock price, and market status.

Is Curiteva, Inc. a public or private company?

Curiteva, Inc. is a private company.

What is the current stock price of Curiteva, Inc.?

Curiteva, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Curiteva, Inc. worth (valuation)?

Valuation information for Curiteva, Inc. is not publicly available.

Can I buy Curiteva, Inc. stock?

Curiteva, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Curiteva, Inc.'s last funding round?

Curiteva, Inc.'s most recent funding round was Seed Round on January 5, 2024.

Who are the main investors in Curiteva, Inc.?

Key investors in Curiteva, Inc. include Eastside Partners.

Will Curiteva, Inc. IPO soon?

No public IPO plans have been announced for Curiteva, Inc..

How can I track Curiteva, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Curiteva, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTanner, Washington
Employee Range56
Year Founded2017
Last FundingJan 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?